Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Holocarboxylase Synthetase Deficiency

ClinicalTrials.gov lists 2 trials for Holocarboxylase Synthetase Deficiency or a narrower condition beneath it.

MeSH D028922 Congenital / Hereditary / Neonatal C16 C18 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 2 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Prevalence Prevalence 6 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 2 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Prevalence Prevalence 6 Rare-disease identity Rare-disease identity 2

Rows recorded per section

4 sections measured, none recorded · 1 not measured yet · 1 not computed

2 of the 2 trials are tagged with Holocarboxylase Synthetase Deficiency itself; the rest are tagged with a narrower condition beneath it.

Get the Holocarboxylase Synthetase Deficiency report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Holocarboxylase Synthetase Deficiency trials start? (2)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2022 1
2018 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Holocarboxylase Synthetase Deficiency trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Observational 2

How many Holocarboxylase Synthetase Deficiency trials are recruiting? (2)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Active, not recruiting 1
Completed 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Prevalence (6)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Holocarboxylase synthetase deficiency Point prevalence Unknown Worldwide Not stated Exact
Holocarboxylase synthetase deficiency Prevalence at birth 1-9 / 1 000 000 Europe Not stated Exact
Holocarboxylase synthetase deficiency Prevalence at birth 1-9 / 1 000 000 Europe Not stated Unspecified
Holocarboxylase synthetase deficiency Point prevalence Unknown Worldwide Not stated Unspecified
Holocarboxylase synthetase deficiency Point prevalence Unknown Worldwide Not stated Exact

Showing 5 of 6 prevalence observations.

Start your 14-day trial Email me all 6 prevalence observations as a PDF

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Holocarboxylase synthetase deficiency 79242 Exact Orphadata Science knowledge files, Product 1
Holocarboxylase synthetase deficiency 79242 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, publications, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages